REFRACTORY LYMPHOPLASMACYTIC LYMPHOMA

Clinical trials for REFRACTORY LYMPHOPLASMACYTIC LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY LYMPHOPLASMACYTIC LYMPHOMA trials appear

Sign up with your email to follow new studies for REFRACTORY LYMPHOPLASMACYTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 4

New pill aims to turn immune system against tough blood cancers

Disease control Recruiting now

This early-stage study is testing a new oral medication called Q702 for patients with advanced blood cancers and rare immune cell disorders that have not responded to standard treatments. The main goals are to find the safest dose and see what side effects occur. Researchers hope…

Matched conditions: REFRACTORY LYMPHOPLASMACYTIC LYMPHOMA

Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated Mar 12, 2026 13:52 UTC

REFRACTORY LYMPHOPLASMACYTIC LYMPHOMA

Get alerted when new REFRACTORY LYMPHOPLASMACYTIC LYMPHOMA trials appear

New pill aims to turn immune system against tough blood cancers